Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Net Margin (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Net Margin for 2 consecutive years, with 47.07% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 17780.0% to 47.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 70.33% through Dec 2025, up 8570.0% year-over-year, with the annual reading at 70.35% for FY2025, 243.0% up from the prior year.
  • Net Margin for Q4 2025 was 47.07% at Day One Biopharmaceuticals, up from 49.48% in the prior quarter.
  • The five-year high for Net Margin was 38.22% in Q3 2024, with the low at 1372.03% in Q2 2024.